Companies / Gilead Sciences
Gilead Sciences
Company- Registered trials
- 1198
- Ongoing
- 182/ 15%
- Completed
- 749
- Related drugs
- 8
- Related conditions
- 13
Clinical trial landscape
1198 registered studies reference this company or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 2 | 304 | 53 | 189 | |
| Phase 3 | 242 | 30 | 171 | |
| Phase 1 | 162 | 20 | 108 | |
| Unknown | 154 | 36 | 79 | |
| Phase 4 | 147 | 11 | 97 | |
| Not applicable | 95 | 15 | 58 | |
| Phase 1/2 | 59 | 8 | 28 | |
| Phase 2/3 | 32 | 8 | 17 | |
| Early Phase 1 | 3 | 1 | 2 | |
| All phases | 1198 | 182 | 749 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.